Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 6
270
Views
81
CrossRef citations to date
0
Altmetric
Research Article

Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences

, , &
Pages 575-588 | Published online: 22 Sep 2008

References

  • CHANG, T. K., ANDERSON, M. D., BANDIERA, S. M. and BELLWARD, G. D., 1997, Effect of ovariectomy and androgen on phenobarbital induction of hepatic CYP2B1 and CYP2B2 in Sprague-Dawley rats. Drug Metabolism and Disposition, 25, 994–1000.
  • CHANG, T. K. H., GONZALEZ, F. J. and WAXMAN, D. J., 1994, Evaluation of triacetyloleandomycin, alpha-naphthofiavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Archives of Biochemistry and Biophysics, 311, 437–442.
  • CIACCIO, P. J., DUIGNAN, D. B. and HALPERT, J. R., 1987, Selective inactivation of the major phenobarbital inducible is ozyme of dog liver cytochrome P-450. Drug Metabolism and Disposition, 15, 852–856.
  • CIACCIO, P. J. and HALPERT, J. R., 1989, Characterization of a phenobarbital-inducible dog liver cytochrome P450 structurally related to rat and human enzymes of the P450IIIA (steroid-inducible) gene subfamily. Archives of Biochemistry and Biophysics, 271, 284–299.
  • COURT, M. H., 1999, Anaesthesia of the sighthound. Clinical Techniques in Small Animal Practice, 14, 38–43.
  • COURT, M. H., HAY-KRAUS, B. L., HILL, D. W., KIND, A. J. and GREENBLATT, D. J., 1999, Propofol hydroxylation by dog liver microsomes: assay development and dog breed differences. Drug Metabolism and Disposition, 27, 1293–1299.
  • COURT, M. H., VON MOLTKE, L. L., SHADER, R. I. and GREENBLATT, D. J., 1997, Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species. Biopharmaceutics and Drug Disposition, 18, 213–226.
  • EAGLING, V. A., TIIA, J. F. and BACK, D. J., 1998, Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. British Journal of Clinical Pharmacology, 45, 107–114.
  • EGUCHI, K., NISHIBE, Y., BABA, T. and OHNO, K., 1996, Quantitation of cytochrome P450 enzymes (CYP1A1/2,2B11,2C21 and 3Al2) in dog liver microsomes by enzyme-linked immunosorbent assay. Xenobiotica, 26, 755–763.
  • GRANVIL, C. P., MADAN, A., SHARKAWI, M., PARKINSON, A. and WAINER, I. W., 1999, Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes. Drug Metabolism and Disposition, 27, 533–541.
  • GUITTON, J., BURONFOSSE, T., DESAGE, M., FLINOIS, J.-P., PERDRIX, J.-P., BRAZIER, J.-L. and BEAUNE, P., 1998, Possible involvement of multiple cytochrome P450 isoforms in the liver metabolism of propofol. British Journal of Anaesthesia, 80, 788–795.
  • HALPERT, J., BALFOUR, C., MILLER, N. E., MORGAN, E. T., DUNBAR, D. and KAMINSKY, L. S., 1985, Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo. Molecular Pharmacology, 28, 290–296.
  • KLEKOTKA, P. A. and HALPERT, J. R., 1995, Benzyloxyresoruhn as a specific substrate for the major phenobarbital-inducible dog liver cytochrome P450 (P4502 B11). Drug Metabolism and Disposition, 23, 1434–1435.
  • LARSEN, M. C., BRAKE, P. B., PARMAR, D. and JEFCOATE, C. R., 1994, The induction of 5 rat hepatic P450 cytochromes by phenobarbital and similarly acting compounds is regulated by a sexually dimorphic, dietary-dependent endocrine factor that is highly strain specific. Archives of Biochemistry and Biophysics, 315, 24–34.
  • LEGUELLEC, C., LACARELLE, B., VILLARD, P.-H., POINT, H., CATALIN, J. and DURAND, A., 1995, Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of different drugs. Anaesthesi7 and Analgesia, 81, 855–861.
  • LIN, J. H., CHIBA, M., CHEN, I. W., NISHIME, J. A. and VASTAG, K. J., 1996, Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence. Drug Metabolism and Disposition, 24, 1298–1306.
  • MANDSAGER, R. E., CLARKE, C. R., SHAWLEY, R. V. and HAGUE, C. M., 1995, Effects of chloramphenicol on infusion pharmacokinetics of propofol in greyhounds. American Journal of Veterinary Research, 56, 95–99.
  • NEWTON, D. J., WANG, R. W. and Lu, A. Y., 1995, Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154–158.
  • NISHIBE, Y., WAKABAYASHI, M., HARAUCHI, T. and OHNO, K., 1998, Characterization of cytochrome P450 (CYP3Al2) induction by rifampicin in dog. Xenobiotica, 28, 549–557.
  • ROBERTSON, S. A., JOHNSTON, S. and BEEMSTERBOER, J., 1992, Cardiopulmonary, anaesthetic and postanesthetic effects of intravenous infusions of propofol in greyhounds and non-greyhounds. American Journal of Veterinary Research, 53, 1027–1032.
  • ROUSSEL, F., DUIGNAN, D. B., LAWTON, M. P., OBACH, R. S., STRICK, C. A. and TWEEDIE, D. J., 1998, Expression and characterization of canine cytochrome P450 2D15. Archives of Biochemistry and Biophysics, 357, 27–36.
  • SIMONS, P. J., COCKSHOTT, I. D., DOUGLAS, E. L., GORDON, E. A., KNOTT, S. and RUANE, R. J., 1991, Species differences in blood profiles, metabolism and excretion of '4C-propofol after intravenous dosing to rat, dog and rabbit. Xenobiotica, 21, 1243–1256.
  • STRESSER, D. M. and KUPFER, D., 1999, Monospecific antipeptide antibody to cytochrome P-450 2B6. Drug Metabolism and Disposition, 27, 517–525.
  • VON MOLTKE, L. L., GREENBLATT, D. J., HARMATZ, J. S. and SHADER, R. I., 1993, Alprazolam metabolism in vitro: Studies of human, monkey, mouse and rat liver microsomes. Pharmacology, 47, 268–276.
  • ZORAN, D. L., RIEDESEL, D. H. and DYER, D. C., 1993, Pharmacokinetics of propofol in mixed-breed dogs and greyhounds. American Journal of Veterinary Research, 54, 755–760.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.